XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 28, 2025
Fair Value Measurements [Abstract]  
Schedule of Financial Assets and Liabilities that are Measured at Fair Value, on a Recurring Basis

The following table sets forth the Company’s financial assets and liabilities that are measured at fair value, on a recurring basis (in thousands):

 

   As of September 28, 2025 
   Level 1   Level 2   Level 3   Total 
Financial Assets                    
Restricted cash  $3,841   $   $   $3,841 
Total  $3,841   $   $   $3,841 
Financial Liabilities                    
July 2024 Notes derivative liability  $   $   $21,664   $21,664 
July 2024 Notes derivative liability – related parties           13,940    13,940 
September 2024 derivative liability           53,301    53,301 
September 2024 derivative liability – related parties           5,922    5,922 
July 2025 Note derivative liability– related party           3,468    3,468 
September 2025 Notes derivative liability           16,274    16,274 
Forward purchase agreement liabilities            4,301    4,301 
Public warrants           2,588    2,588 
Private placement warrants           1,880    1,880 
Working capital warrants           215    215 
SAFE Agreement with related party           497    497 
Total  $   $   $124,050   $124,050 

 

   As of December 29, 2024 
   Level 1   Level 2   Level 3   Total 
Financial Assets                
Restricted cash  $3,841   $   $   $3,841 
Total  $3,841   $   $   $3,841 
Financial Liabilities                    
July 2024 Notes derivative liability  $   $   $13,563   $13,563 
July 2024 Notes derivative liability – related parties           21,127    21,127 
September 2024 Notes derivative liability           55,474    55,474 
September 2024 Notes derivative liability – related parties           6,958    6,958 
Forward purchase agreement liabilities (1)           3,494    3,494 
Public warrants           862    862 
Private placement warrants           627    627 
Working capital warrants           72    72 
SAFE Agreement with related party           384    384 
Total  $   $   $102,561   $102,561 

 

(1) Includes $1.3 million due to related parties as of and December 29, 2024.
Schedule of Derivative Liability Valuation Inputs

The July 2024 Notes derivative liability valuation included the following inputs:

 

   As of 
   September 28,
2025
   December 29,
2024
 
Coupon rate   12.0%   12.0%
Conversion rate   595.24    595.24 
Conversion price  $1.68   $1.68 
Common stock price  $1.77   $1.81 
Risk-free rate   3.7%   4.43%
Volatility   73.9%   62.0%
Dividend yield   0.0%   0.0%

 

The September 2024 Notes derivative liability valuation included the following inputs:

 

   As of 
   September 28,
2025
   December 29,
2024
 
Coupon rate   7.0%   7.0%
Conversion rate   467.84    467.84 
Conversion price  $2.14   $2.14 
Common stock price  $1.77   $1.81 
Risk-free rate   3.7%   4.43%
Volatility   77.8%   66.6%
Dividend yield   0.0%   0.0%

 

The July 2025 Note derivative liability valuation included the following inputs:

 

   As of 
   September 28,
2025
 
Coupon rate   12.0%
Conversion rate   558.66 
Conversion price  $1.79 
Common stock price  $1.77 
Risk-free rate   3.7%
Volatility   75.1%
Dividend yield   0.0%

 

The September 2025 Notes derivative liability valuation included the following inputs:

 

   As of 
   September 28,
2025
 
Coupon rate   7.0%
Conversion rate   467.84 
Conversion price  $2.14 
Common stock price  $1.77 
Risk-free rate   3.7%
Volatility   77.8%
Dividend yield   0.0%
Schedule of Measured at Fair Value The Company valued the private placement and working capital warrants, based on a Black-Scholes Option Pricing Method, which included the following inputs:
   As of 
   September 28,   December 29, 
   2025   2024 
Expected term   2.81 years    3.56 years 
Expected volatility   169.0%   68.1%
Risk-free rate   3.65%   4.39%
Expected dividend yield   0.00%   0.00%
The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
   As of 
   September 28,   December 29, 
   2025   2024 
VWAP  $1.86   $1.78 
Simulation period   0.80 years    0.55 years 
Risk-free rate   3.73%   4.28%
Volatility   84.8%   117%
Schedule of Financial Liabilities that were not Measured at Fair Value, on a Non-Recurring Basis The following table sets forth the Company’s financial liabilities that were not measured at fair value, on a non-recurring basis (in thousands):
   As of September 28, 2025 
       Fair value 
   Carrying
value
   Estimated
fair value
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                              
July 2024 Notes  $36,998   $34,187   $   $   $34,187   $34,187 
July 2024 Notes – related parties   8,155    22,042            22,042    22,042 
September 2024 Notes   15,750    78,563            78,563    78,563 
September 2024 Notes – related parties   1,714    8,729            8,729    8,729 
July 2025 Note – related party   1,373    6,250            6,250    6,250 
September 2025 Notes   4,218    25,090            25,090    25,090 
Total  $68,208   $174,861   $   $   $174,861   $174,861 

 

   As of December 29, 2024 
       Fair value 
   Carrying
value
   Estimated
fair value
   Level 1   Level 2   Level 3   Total 
Financial Liabilities                        
July 2024 Notes  $17,965   $21,390   $   $   $21,390   $21,390 
July 2024 Notes - related parties   24,632    33,323            33,323    33,323 
September 2024 Notes   5,636    77,245            77,245    77,245 
September 2024 Notes - related parties   476    8,583            8,583    8,583 
Total  $48,709   $140,541   $   $   $140,541   $140,541